Announcing a new article publication for BIO Integration journal. The pyrimidine analog 5-flurouracil (5-FU) is effective against solid tumors. However, the half-life of intravenously administered ...

Calcipotriol plus 5-FU immunotherapy activates Th2 immunity, releasing IL-24 cytokines to suppress skin cancer development in patients with actinic keratosis. The combination therapy significantly ...

New research reveals how calcipotriol-plus–5-FU therapy activates immune pathways to prevent squamous cell carcinoma with long-lasting protection. Study: T helper 2 cell–directed immunotherapy ...

A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the ...